9780521773218

Drugs for the Treatment of Respiratory Diseases

by
  • ISBN13:

    9780521773218

  • ISBN10:

    0521773210

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2003-03-24
  • Publisher: Cambridge University Press
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $394.00 Save up to $34.00
  • Buy New
    $382.18
    Add to Cart Free Shipping

    SPECIAL ORDER: 1-2 WEEKS

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The eBook copy of this book is not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Summary

Respiratory diseases affect millions of people each year and represent a major health burden around the world. This timely reference surveys and evaluates the drug treatments available for the main categories of lung diseases including asthma, tuberculosis, chronic obstructive pulmonary disease, lung cancer, and respiratory infections. The recent re-emergence of tuberculosis and the increase in asthma in certain populations underlines the importance of finding effective new treatments for these diseases. This publication, a comprehensive reference, is one of the first to survey current and novel drug treatments for this group of diseases. It is certain to establish itself as an essential source of reference for respiratory physicians, clinicians and clinical pharmacologists.

Table of Contents

Part I. Asthma and COPD: 1. Pathology of asthma and COPD Peter K. Jeffery
2. Glucocorticosteroids Peter J. Barnes
3. ß
2- adrenoceptor agonists Domenico Spina, Clive P. Page and Brian J. O'Connor
4. Anticholinergic bronchodilators Jeremy M. Segal and Nicholas J. Gross
5. Antiallergic drugs Mazakazu Ichinose
6. Drugs affecting the synthesis and action of leukotrienes Paul M. O'Byrne
7. Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease N. A. Jones, Domenico Spina and Clive P. Page
8. Potential therapeutic effects of potassium channel openers in respiratory diseases Ahmed Z. El-Hashim
9. Tachykinin and kinin antagonists Pierangelo Geppetti
10. Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) Lawrence G. Garland and Alan G. Lamont
11. Drugs targeting cell signalling Brydon L. Bennett, Yoshitaka Satoh and Alan J. Lewis
Part II. Diffuse Parenchymal Lung Disease: 12. Current approaches to the treatment of parenchymal lung diseases Joseph P. Lynch III and Michael Keane
13. Drug treatments of the future in fibrotic lung disease Athol U. Wells
Part III. Infection: 14. Current and future management of pneumonia Mario Cazzola and Maria G. Matera
15. Current treatment of chronic bronchial suppuration Robert Wilson
16. Current and future treatment of cystic fibrosis R. Gary, G. Ruiz, Hilary Wyatt and John F. Price
Part IV. Pulmonary Vascular Diseases: 17. Pathophysiology of pulmonary vascular disease Sanjay Mehta and David G. McCormack
18. Current treatment of pulmonary vascular diseases Tarek Saba and Andrew Peacock
19. Future treatment of pulmonary vascular diseases Norbert F. Voelkel, M. W. Geraci and S. Abman
Part V. Lung Cancer:20. Molecular pathology of lung cancer Ignacio I. Wistuba and Adi F. Gazdar
21. Small cell lung cancer Desmond N. Carney
Part VI. Cough: 22. Mechanisms of cough John J. Adcock
23. Current treatment of cough Peter V. Dicpinigaitis.

Rewards Program

Write a Review